The cryoSPHERE® MAX offers a non-opioid solution for managing post-op pain—targeting intercostal nerves with a 60-second freeze that temporarily interrupts pain signals.
Explore the science behind #cryoNB: https://okt.to/3UqKvC#PainManagement
Interested in advancing your role in post-op pain management? Join us in Miami on October 24 for a hands-on course designed for APPs and early career providers involved in thoracic surgery care.
This workshop dives into multimodal pain strategies, including Cryo Nerve Block (cryoNB), and explores how APPs play a key role in improving patient outcomes after thoracotomy procedures.
Learn more and register here: https://okt.to/4gi1rY
We’re celebrating two incredible milestones in New York today. It marks 20 years since AtriCure became a publicly traded company on the Nasdaq (ATRC) and 25 years since our founding. From a small, passionate team in 2000 to a global presence today, we’ve expanded treatment options for Afib, cardiac surgery, and post-operative pain—all while keeping patients at the heart of everything we do.
Through two decades of clinical trials, research and innovation, we’ve helped treat over 1 million patients, and we’re just getting started.
#Nasdaqlisted#AllWaysInnovating
Our Heart of AtriCure recipients demonstrate a commitment to quality, exemplify our patient-first focus, and embody our values at the heart of everything they do. Thank you and congratulations to Stacey, Adam, Kathe, Kirstin, Nan, and Cris.
We're celebrating the bright minds who bring fresh energy, curiosity, and ideas to our team. Hear what our interns have to say about their experience at AtriCure! #InternDay
Individuals with symptomatic IST typically have heart rates greater than 100 beats per minute even with minimal activity.
The HEAL-IST Trial is currently enrolling patients to evaluate whether a hybrid sinus node sparing procedure is a safe and effective treatment option for symptomatic and drug-resistant IST patients.
See candidate qualifications at: heal-ist.com
#IST#InnapropriateSinusTachycardia#ClinicalTrial
Happy 4th of July! Today we take a moment to appreciate the independence we enjoy and the freedoms that shape our everyday lives. Wishing everyone a safe and happy holiday.
#IndependenceDay#FourthOfJuly
The cryoSPHERE® MAX offers a non-opioid solution for managing post-op pain—targeting intercostal nerves with a 60-second freeze that temporarily interrupts pain signals.
Explore the science behind #cryoNB: https://t.co/d0G65VInGD#PainManagement
Join us in Miami on Oct 24 for a hands-on course tailored for APPs and early career providers in thoracic surgery.
Get practical insights on multimodal strategies and how they can improve outcomes after thoracotomy.
Learn more and register here: https://t.co/uChpqgkXZO
Today we’re celebrating 20 years on @Nasdaq (ATRC) and 25 years since AtriCure’s founding! From a small team in 2000 to a global presence, we’ve expanded Afib, cardiac surgery & post-op pain treatment—always with a patient-first focus.
#Nasdaqlisted#AllWaysInnovating
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
AtriCure: Impacting Lives, One Patient at a Time
Duration: 4:5
AtriClip FLEX∙V® Device Animation
Duration: 2:9
AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion
Duration: 3:47
Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices
Duration: 1:25
social media channels to keep updated on the latest at AtriCure.